Search Within

Allison Betof Warner

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (8)
  3. Review (1)
Groups
  1. Department of Medicine (20)
  2. Hematologic Malignancies, Division of (20)
  3. Melanoma and Immunotherapeutics Service (20)
  4. Population Sciences Research Program (20)
  5. Solid Tumor Oncology Division (20)
  6. Weinberg Fellows (20)

More Groups

People
  1. Jedd Wolchok (18)
  2. Katherine Panageas (18)
  3. Michael Postow (17)
  4. Alexander Shoushtari (16)
  5. Paul Chapman (15)
  6. Margaret Callahan (14)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (3)
  6. 2019 (3)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Clinical Cancer Research (2)
  3. Journal for ImmunoTherapy of Cancer (2)
  4. Annals of Surgical Oncology (1)
  5. CNS Oncology (1)
  6. Cancer Medicine (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. American Association for Cancer Research (2)
  3. Biomed Central Ltd (2)
  4. Wiley Blackwell (2)
  5. American Association for the Advancement of Science (1)
  6. Elsevier Inc. (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study
    Journal Article

    Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Betof Warner, A.; Postow, M. A.; Panageas, K.; Smithy, J. W.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final clinical results and first translational correlates of a phase 2 trial of adaptively dosed nivolumab and ipilimumab based on early radiographic assessment in advanced melanoma (ADAPT-IT)
    Meeting Abstract

    Smithy, J. W.; Kalvin, H. L.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Decision-making and health-related quality of life in patients with melanoma considering adjuvant immunotherapy
    Journal Article

    Atkinson, T. M.; Hay, J. L.; Kim, S. Y.; Schofield, E.; Postow, M. A.; Momtaz, P.; Warner, A. B.; Shoushtari, A. N.; Callahan, M. K.; Wolchok, J. D.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Efficacy of immunotherapy for melanoma brain metastases in patients with concurrent corticosteroid exposure
    Journal Article

    Tringale, K. R.; Reiner, A. S.; Sehgal, R. R.; Panageas, K.; Warner, A. S. B.; Postow, M. A.; Moss, N. S.
    CNS Oncology (2023)

    Fulltext@MSK | Save
  • Adaptive dosing of nivolumab + ipilimumab immunotherapy based upon early, interim radiographic assessment in advanced melanoma (The ADAPT-IT study)
    Journal Article

    Postow, M. A.; Goldman, D. A.; Shoushtari, A. N.; Betof Warner, A.; Callahan, M. K.; Momtaz, P.; Smithy, J. W.; Naito, E.; Cugliari, M. K.; Raber, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Characteristics and probability of survival for patients with advanced melanoma who live five or more years after initial treatment with immune checkpoint blockade (ICB)
    Meeting Abstract

    Loo, K.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
    Journal Article

    Chapman, P. B.; Jayaprakasam, V. S.; Panageas, K. S.; Callahan, M.; Postow, M. A.; Shoushtari, A. N.; Wolchok, J. D.; Betof Warner, A.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
    Journal Article

    Shen, R.; Postow, M. A.; Adamow, M.; Arora, A.; Hannum, M.; Maher, C.; Wong, P.; Curran, M. A.; Hollmann, T. J.; Jia, L.; more...
    Science Translational Medicine (2021)

    Fulltext@MSK | Save